Dean Fergusson
dafergusson@ohri.ca

Program Director and Senior Scientist, Clinical Epidemiology, Ottawa Hospital Research Institute
OHRI/uOttawa Clinical Epidemiology Program Endowed Chair
Associate Professor, Faculty of Medicine, Departments of Medicine, Epidemiology & Community Medicine, and of Surgery, University of Ottawa
Epidemiologist, University of Ottawa Centre for Transfusion Research
Associate, Clinical Trials Research Group, Biomedical Ethics Unit, McGill University
Research Interests
Transfusion EpidemiologyClinical Trials
Research Ethics
Major Research Activities
Dean Fergusson's clinical research interests are in the field of transfusion medicine. Specifically, he has focused much of his research on transfusion alternatives and the effectiveness of blood products. His current work in clinical trials methodology and ethics concerns clinical equipoise, the ethics of placebo-controlled trials and issues related to establishing the efficacy of blinding in trials.
Most Recent Publications (provided by The Ottawa Hospital Library Database)
Hebert PC;Fergusson D;Stanbrook MB;, (2011 Jan 11), Off-label use of recombinant factor VIIa: why we need better drug monitoring, CMAJ, Vol.183, Issue 1, 26-27Goodnough LT;Maniatis A;Earnshaw P;Benoni G;Beris P;Bisbe E;Fergusson DA;Gombotz H;Habler O;Monk TG;Ozier Y;Slappendel R;Szpalski M;, (2011 Jan), Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines, Br J Anaesth, Vol.106, Issue 1, 13-22 -> view abstract
Lavallee LT;Fergusson D;Breau RH;, (2011 Feb 1), The role of randomized controlled trials in evidence-based urology, World J Urol, -> view abstract
Blair J;Hodge W;Al-Ghamdi S;Balabanian R;Lowcock B;Pan YI;Sherif H;Almahmoud T;Fergusson D;Slomovic A;, (2011 Feb), Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial, Can J Ophthalmol, Vol.46, Issue 1, 40-45 -> view abstract
Henry DA;Carless PA;Moxey AJ;O'Connell D;Stokes BJ;Fergusson DA;Ker K;, (2011), Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, Vol.1, CD001886 -> view abstract
Vigneault L;Turgeon AF;Cote D;Lauzier F;Zarychanski R;Moore L;McIntyre LA;Nicole PC;Fergusson DA;, (2010 Nov 9), Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials, Can J Anaesth, -> view abstract
Aaron SD;Vandemheen KL;Ramotar K;Giesbrecht-Lewis T;Tullis E;Freitag A;Paterson N;Jackson M;Lougheed MD;Dowson C;Kumar V;Ferris W;Chan F;Doucette S;Fergusson D;, (2010 Nov 17), Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis, JAMA, Vol.304, Issue 19, 2145-2153 -> view abstract
Clavet H;Hebert PC;Fergusson DA;Doucette S;Trudel G;, (2010 May 7), Joint contractures in the intensive care unit: association with resource utilization and ambulatory status at discharge, Disabil Rehabil, Vol.33, Issue 2, 105-112 -> view abstract
Schulz KF;Altman DG;Moher D;Fergusson D;, (2010 Mar 23), CONSORT 2010 changes and testing blindness in RCTs, Lancet, Vol.375, Issue 9721, 1144-1146
White CA;Akbari A;Doucette S;Fergusson D;Knoll GA;, (2010 Mar), Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better?, Clinical Chemistry, Vol.56, Issue 3, 474-477 -> view abstract
Note: This is not a complete list of publications. More publications may be available in The Ottawa Hospital Library database and Pubmed (search by last name and initials).
